X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Panacea Biotech with Lupin Ltd - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PANACEA BIOTECH vs LUPIN LTD - Comparison Results

PANACEA BIOTECH    Change

Panacea Biotec is the second largest vaccine producer in India and has been ranked as the third largest biotechnology company in India (as per ABLE Survey 2006). While vaccines account for two-thirds of the company's overall revenues, the balance com... More

LUPIN LTD 
   Change

Lupin is a leading pharmaceutical company with a strong presence in anti-infective, cardiovascular and asthma. Apart from having a strong domestic presence, the company markets its products in the regulated markets of the US and Europe and semi-regul... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    PANACEA BIOTECH LUPIN LTD PANACEA BIOTECH/
LUPIN LTD
 
P/E (TTM) x 155.4 22.9 678.7% View Chart
P/BV x 3.5 3.1 111.3% View Chart
Dividend Yield % 0.0 0.8 -  

Financials

 PANACEA BIOTECH   LUPIN LTD
EQUITY SHARE DATA
    PANACEA BIOTECH
Mar-14
LUPIN LTD
Mar-17
PANACEA BIOTECH/
LUPIN LTD
5-Yr Chart
Click to enlarge
High Rs1491,750 8.5%   
Low Rs821,384 5.9%   
Sales per share (Unadj.) Rs84.1387.4 21.7%  
Earnings per share (Unadj.) Rs-18.356.6 -32.3%  
Cash flow per share (Unadj.) Rs-6.776.8 -8.7%  
Dividends per share (Unadj.) Rs07.50 0.0%  
Dividend yield (eoy) %00.5 0.0%  
Book value per share (Unadj.) Rs83.7298.9 28.0%  
Shares outstanding (eoy) m61.25451.58 13.6%   
Bonus/Rights/Conversions -ESOPS-  
Price / Sales ratio x1.44.0 33.9%   
Avg P/E ratio x-6.327.7 -22.8%  
P/CF ratio (eoy) x-17.220.4 -84.6%  
Price / Book Value ratio x1.45.2 26.3%  
Dividend payout %013.2 0.0%   
Avg Mkt Cap Rs m7,074707,513 1.0%   
No. of employees `0002.816.8 16.4%   
Total wages/salary Rs m1,44928,495 5.1%   
Avg. sales/employee Rs Th1,874.110,418.3 18.0%   
Avg. wages/employee Rs Th527.01,697.0 31.1%   
Avg. net profit/employee Rs Th-407.71,523.0 -26.8%   
INCOME DATA
Net Sales Rs m5,154174,943 2.9%  
Other income Rs m1001,065 9.4%   
Total revenues Rs m5,254176,008 3.0%   
Gross profit Rs m-76644,931 -1.7%  
Depreciation Rs m7119,122 7.8%   
Interest Rs m1,5031,525 98.5%   
Profit before tax Rs m-2,88135,349 -8.1%   
Minority Interest Rs m11-72 -15.1%   
Prior Period Items Rs m-683 -6.9%   
Extraordinary Inc (Exp) Rs m1,7710-   
Tax Rs m179,785 0.2%   
Profit after tax Rs m-1,12125,575 -4.4%  
Gross profit margin %-14.925.7 -57.9%  
Effective tax rate %-0.627.7 -2.1%   
Net profit margin %-21.814.6 -148.8%  
BALANCE SHEET DATA
Current assets Rs m3,810119,542 3.2%   
Current liabilities Rs m8,36561,206 13.7%   
Net working cap to sales %-88.433.3 -265.1%  
Current ratio x0.52.0 23.3%  
Inventory Days Days15676 204.9%  
Debtors Days Days6790 74.8%  
Net fixed assets Rs m14,480131,660 11.0%   
Share capital Rs m61903 6.8%   
"Free" reserves Rs m903134,073 0.7%   
Net worth Rs m5,127134,976 3.8%   
Long term debt Rs m5,83256,478 10.3%   
Total assets Rs m19,433266,073 7.3%  
Interest coverage x-0.924.2 -3.8%   
Debt to equity ratio x1.10.4 271.8%  
Sales to assets ratio x0.30.7 40.3%   
Return on assets %2.010.2 19.3%  
Return on equity %-21.918.9 -115.4%  
Return on capital %3.619.3 18.9%  
Exports to sales %24.50-   
Imports to sales %10.20-   
Exports (fob) Rs m1,264NA-   
Imports (cif) Rs m525NA-   
Fx inflow Rs m1,53981,885 1.9%   
Fx outflow Rs m94221,506 4.4%   
Net fx Rs m59760,378 1.0%   
CASH FLOW
From Operations Rs m59941,148 1.5%  
From Investments Rs m-438-25,287 1.7%  
From Financial Activity Rs m-3034,332 -7.0%  
Net Cashflow Rs m-14120,193 -0.7%  

Share Holding

Indian Promoters % 74.5 46.6 159.9%  
Foreign collaborators % 0.0 0.2 -  
Indian inst/Mut Fund % 0.6 11.3 5.3%  
FIIs % 1.3 31.9 4.1%  
ADR/GDR % 0.0 0.0 -  
Free float % 23.6 10.1 233.7%  
Shareholders   10,259 98,259 10.4%  
Pledged promoter(s) holding % 35.1 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare PANACEA BIOTECH With:   DR. DATSONS LABS  DISHMAN PHARMA  J.B.CHEMICALS  JUBILANT LIFE SCIENCES  DIVIS LABORATORIES  

Compare PANACEA BIOTECH With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Trades on a Positive Note; Apollo Micro Systems IPO Lists at 74% Premium(11:30 am)

Stock markets in India are presently trading marginally higher. Sectoral indices are trading on a mixed note with stocks in the energy sector and IT sector witnessing maximum buying interest.

Related Views on News

Lupin: US Markets Drags down Revenues and Net Profits (Quarterly Results Update - Detailed)

Nov 2, 2017

Domestic markets registers robust growth in the quarter

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Lupin: Decline in US Business Impacts Overall Growth (Quarterly Results Update - Detailed)

May 29, 2017

Currency fluctuation and one time provision impacts operating margins.

Lupin: US Business Drives Growth (Quarterly Results Update - Detailed)

Mar 8, 2017

Lupin has announced its 3QFY17 results. Net sales have grown by 31.5% YoY and net profits have surged by 20.7% YoY. Here is our analysis of the results.

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

Retail Investors or Chickens Waiting to Get Slaughtered in the Stock Market?(Vivek Kaul's Diary)

Jan 9, 2018

The price to earnings ratio of the Nifty 50 is very close to all-time high levels.

Best ELSS Funds In 2018: Don't Blindly Chase Top Performers(Outside View)

Jan 10, 2018

As the tax-saving season begins, investors hunt for the best ELSS funds for 2018. PersonalFN provides a list of the top ELSS mutual funds of the past year.

Did GST and Notebandi Help? Sherlock Holmes Finds Out...(The 5 Minute Wrapup)

Jan 13, 2018

Discussions with my cousin helped me understand the situation on Ground Zero - after the demonetization and GST upheaval. Here's what that means for listed companies...

Bitcoin Beginners Should Do These Three Things...(Smart Contrarian)

Jan 10, 2018

Three simple points to keep in mind before you consider buying bitcoin.

Nirvana denied: Has Value Failed?(The Honest Truth)

Jan 13, 2018

Should investors choose growth over value this year?

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

PANACEA BIOTECH SHARE PRICE


Jan 22, 2018 01:31 PM

TRACK PANACEA BIOTECH

  • Track your investment in PANACEA BIOTECH with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON PANACEA BIOTECH

PANACEA BIOTECH 8-QTR ANALYSIS

COMPARE PANACEA BIOTECH WITH

MARKET STATS